{"id":"n-normal-saline-placebo","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperchloremic acidosis (with prolonged high-volume infusion)"},{"rate":null,"effect":"Fluid overload"},{"rate":null,"effect":"Local irritation at injection site"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Normal saline (0.9% sodium chloride in water) is a sterile solution that matches the osmolarity and electrolyte composition of human blood plasma. It is used as a vehicle for drug delivery, a flush solution, or as a placebo control in clinical trials. It has no intrinsic therapeutic mechanism beyond maintaining fluid balance and electrolyte homeostasis.","oneSentence":"Normal saline is an inert isotonic solution that serves as a physiological control or placebo with no active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:56:26.791Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Placebo control in clinical trials"},{"name":"Vehicle for intravenous drug delivery"},{"name":"Fluid and electrolyte replacement"}]},"trialDetails":[{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT07273071","phase":"PHASE4","title":"Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections: N-Acetylcysteine","status":"NOT_YET_RECRUITING","sponsor":"Theis S. Itenov","startDate":"2026-07","conditions":"Sepsis, Acute Infection, Severe Infection","enrollment":360},{"nctId":"NCT06735209","phase":"PHASE1","title":"First-in-Human PfSPZ-LARC2 Vaccination/CHMI","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-07-23","conditions":"Malaria","enrollment":22},{"nctId":"NCT07262060","phase":"PHASE2","title":"Improving Preterm Kidney Outcomes With Caffeine","status":"NOT_YET_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2026-04","conditions":"Kidney Injury, Pre-Term","enrollment":102},{"nctId":"NCT06862453","phase":"PHASE1","title":"Safety, Tolerability and Efficacy Against Controlled Human Malaria Infection of PfSPZ-LARC2 Vaccine in Malaria-naïve Adults","status":"NOT_YET_RECRUITING","sponsor":"Sanaria Inc.","startDate":"2026-03","conditions":"Malaria Falciparum","enrollment":58},{"nctId":"NCT04350138","phase":"PHASE2","title":"Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2020-12-29","conditions":"Gonococcal Infection","enrollment":2606},{"nctId":"NCT03418038","phase":"PHASE2","title":"Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-03-23","conditions":"Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Diffuse Large B-Cell Lymphoma","enrollment":80},{"nctId":"NCT06692907","phase":"PHASE2","title":"Efficacy Study of IM Administered CssBA+dmLT Against Moderate-severe Diarrhea in Human Infection Model With ETEC Strain B7A in Healthy Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-03-31","conditions":"Escherichia Infection","enrollment":72},{"nctId":"NCT03822637","phase":"PHASE4","title":"The Effect of NAC on Lung Function and CT Mucus Score","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2019-02-20","conditions":"Asthma","enrollment":4},{"nctId":"NCT07444788","phase":"PHASE1","title":"Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2026-03-31","conditions":"5-methoxy-dimethyltryptamine (5-MeO-DMT)","enrollment":40},{"nctId":"NCT06416462","phase":"NA","title":"Action of Photodynamic Therapy on Wound Quality and Tissue Repair in the Diabetic Foot","status":"COMPLETED","sponsor":"University of Nove de Julho","startDate":"2024-07-30","conditions":"Diabetic Foot Ulcer","enrollment":94},{"nctId":"NCT07412080","phase":"PHASE1","title":"EDP167 in Healthy Volunteers and Subjects With Mild Dyslipidemia","status":"COMPLETED","sponsor":"Eddingpharm (Zhuhai) Co., Ltd.","startDate":"2025-07-01","conditions":"Healthy Adult Male and Female Volunteers, Mild Dyslipidemia","enrollment":40},{"nctId":"NCT06575153","phase":"PHASE1","title":"Phase 1 Study of ART5803 in Healthy Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arialys Therapeutics","startDate":"2024-09-19","conditions":"Autoimmune Encephalitis","enrollment":64},{"nctId":"NCT03470441","phase":"PHASE2","title":"A Study of Acute Myocardial Infarction Using FDY-5301","status":"COMPLETED","sponsor":"Faraday Pharmaceuticals, Inc.","startDate":"2017-10-27","conditions":"Acute Myocardial Infarction, STEMI","enrollment":120},{"nctId":"NCT03065335","phase":"PHASE1","title":"Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder","status":"RECRUITING","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2017-05-25","conditions":"Healthy Volunteer, Major Depressive Disorder, Depression","enrollment":150},{"nctId":"NCT04656535","phase":"EARLY_PHASE1","title":"AB154 Combined With AB122 for Recurrent Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2021-04-21","conditions":"Glioblastoma","enrollment":46},{"nctId":"NCT05453578","phase":"PHASE1, PHASE2","title":"A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-10-03","conditions":"Bacterial Disease Carrier, Cystic Fibrosis","enrollment":72},{"nctId":"NCT06727331","phase":"PHASE2","title":"Study of Tirzepatide for Recovery and Alcohol Use Management","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2025-09-15","conditions":"Alcohol Use Disorder (AUD)","enrollment":20},{"nctId":"NCT07267650","phase":"NA","title":"iPACK Block vs. Periarticular Infiltration for TKA Pain Control","status":"NOT_YET_RECRUITING","sponsor":"Turgutlu State Hospital","startDate":"2026-01-01","conditions":"Pain, Postoperative, Osteoarthritis, Knee / Osteoarthritis, Hip","enrollment":100},{"nctId":"NCT07237425","phase":"PHASE1","title":"Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma","status":"RECRUITING","sponsor":"Glonova Pharma Co., Ltd","startDate":"2025-11-14","conditions":"Lipoma, Submental Fullness","enrollment":56},{"nctId":"NCT07258498","phase":"PHASE4","title":"Submucosal Dexamethasone for Control of Post-operative Pain, Trismus, and Swelling After Mandibular Third Molar Surgery","status":"COMPLETED","sponsor":"PAEC General Hospital, Islamabad","startDate":"2024-10-01","conditions":"Impacted Mandibular Third Molar Extraction","enrollment":70},{"nctId":"NCT06546709","phase":"PHASE1","title":"DMID 23-0015; Lassa Fever CVD 1000","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wilbur Chen, MD, MS","startDate":"2025-01-13","conditions":"Lassa Fever","enrollment":55},{"nctId":"NCT01467466","phase":"PHASE3","title":"Prevention of Serious Adverse Events Following Angiography","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2013-10-07","conditions":"Acute Renal Failure, Kidney Disease, Coronary Artery Disease","enrollment":5177},{"nctId":"NCT05846399","phase":"PHASE4","title":"CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)","status":"RECRUITING","sponsor":"University of Missouri-Columbia","startDate":"2023-09-07","conditions":"Cat Bite, Hand Injuries, Arm Injury","enrollment":72},{"nctId":"NCT06668571","phase":"PHASE2","title":"Intravenous Ketamine for Treatment-Resistant Depression","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-02-10","conditions":"Depressive Disorder, Treatment-Resistant, Treatment Resistant Depression (TRD)","enrollment":30},{"nctId":"NCT06284473","phase":"PHASE4","title":"Ketamine as a Supplement to Local Anesthesia for Minor Procedures","status":"RECRUITING","sponsor":"Loyola University","startDate":"2022-05-25","conditions":"Pain, Procedural, Minor Laceration, Abscess","enrollment":108},{"nctId":"NCT06639464","phase":"PHASE2","title":"Semaglutide for Helping Opioid Recovery","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2025-06-02","conditions":"Opioid Use Disorder","enrollment":46},{"nctId":"NCT06484335","phase":"PHASE1","title":"RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV","status":"RECRUITING","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2025-03-27","conditions":"HIV Infections, PLWH, ART","enrollment":48},{"nctId":"NCT04765722","phase":"PHASE4","title":"Mepolizumab for the Treatment of Chronic Cough With Eosinophilic Airways Diseases","status":"COMPLETED","sponsor":"McMaster University","startDate":"2021-12-14","conditions":"Chronic Cough, Eosinophilic Bronchitis, Asthma","enrollment":46},{"nctId":"NCT07158437","phase":"PHASE1","title":"Phase 1 Study of SL-325 in Healthy Volunteers","status":"RECRUITING","sponsor":"Shattuck Labs, Inc.","startDate":"2025-09","conditions":"Healthy Volunteers","enrollment":72},{"nctId":"NCT06486805","phase":"PHASE4","title":"N-Acetyl Cysteine Effect on Liver Function After Mitral Valve Replacement","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2024-06-30","conditions":"Oxidative Stress, Liver Dysfunction","enrollment":54},{"nctId":"NCT06319274","phase":"PHASE2","title":"Infusion of Prostacyclin vs Placebo for 72-hours in Mechanically Ventilated Patients With Acute Respiratory Failure","status":"RECRUITING","sponsor":"Pär Johansson","startDate":"2024-04-15","conditions":"Acute Respiratory Failure, Endothelial Dysfunction, Pulmonary Infection","enrollment":450},{"nctId":"NCT06683352","phase":"PHASE1, PHASE2","title":"A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2024-11-11","conditions":"Influenza,Human, COVID-19","enrollment":1353},{"nctId":"NCT04960397","phase":"PHASE1","title":"Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-09-10","conditions":"H3N2 Influenza","enrollment":140},{"nctId":"NCT05478720","phase":"PHASE1, PHASE2","title":"DON in Pediatric Cerebral Malaria","status":"RECRUITING","sponsor":"Douglas Postels, MD, MS","startDate":"2022-08-16","conditions":"Malaria, Cerebral","enrollment":152},{"nctId":"NCT04658667","phase":"PHASE1","title":"HIV Vaccine in HIV-uninfected Adults","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2022-02-03","conditions":"HIV","enrollment":81},{"nctId":"NCT03583606","phase":"PHASE1","title":"A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-11-12","conditions":"Ebola Disease, Immunisation","enrollment":61},{"nctId":"NCT06999993","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Sodium Hyaluronate Gel Combined With Sodium Bicarbonate Versus Sodium Bicarbonate Alone in Prevention of Failed Back Surgery Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Misr University for Science and Technology","startDate":"2025-06-20","conditions":"Postdiscectomy Epidural Fibrosis, Pain","enrollment":60},{"nctId":"NCT02952833","phase":"PHASE1","title":"ZIKA Vaccine in Naive Subjects","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-10-14","conditions":"Zika Virus Infection","enrollment":91},{"nctId":"NCT06720220","phase":"PHASE3","title":"Role of Airway Topicalization in Awake Fiberoptic Intubation","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2023-06-01","conditions":"Airway Complication of Anesthesia","enrollment":56},{"nctId":"NCT05944458","phase":"PHASE4","title":"Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients","status":"COMPLETED","sponsor":"Helwan University","startDate":"2023-08-01","conditions":"Linezolid, Antioxidant, Thrombocytopenia","enrollment":250},{"nctId":"NCT03810417","phase":"PHASE4","title":"Preop Digifab in CABG to Reduce Ouabain Levels and Prevent AKI","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2019-07-22","conditions":"Acute Kidney Injury","enrollment":267},{"nctId":"NCT05035342","phase":"PHASE3","title":"Fecal Transplantation to Eradicate Colonizing Emergent Superbugs","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-01-11","conditions":"Enterobacteriaceae Infections, Fecal Microbiota Transplantation","enrollment":214},{"nctId":"NCT06738576","phase":"PHASE1","title":"Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old","status":"RECRUITING","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2024-12-16","conditions":"Urinary Incontinence Stress","enrollment":60},{"nctId":"NCT04242264","phase":"PHASE2","title":"Phase 2 Shigella Vaccine and Challenge","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-10-12","conditions":"Immunisation, Shigella Infection","enrollment":69},{"nctId":"NCT06572085","phase":"PHASE4","title":"Neuroprotective Effect of Butylphthalide for Cardiac Arrest Patients","status":"RECRUITING","sponsor":"Tang Ziren","startDate":"2022-01-01","conditions":"Butylphthalide, Cardiac Arrest, Neuroprotective Drugs","enrollment":350},{"nctId":"NCT05695495","phase":"PHASE1","title":"Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study)","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-06-12","conditions":"Healthy","enrollment":36},{"nctId":"NCT06111339","phase":"PHASE2","title":"Ketamine for OUD and Suicidal Ideation in the ED","status":"TERMINATED","sponsor":"Brigham and Women's Hospital","startDate":"2024-06-14","conditions":"Opioid Use Disorder, Suicidal Ideation","enrollment":4},{"nctId":"NCT06811675","phase":"PHASE4","title":"The Efficacy of Dexamethasone in Combination With N-acetylcysteine in Preventing Neurocognitive Sequelae Due to Carbon Monoxide Poisoning","status":"RECRUITING","sponsor":"China Medical University Hospital","startDate":"2025-03-23","conditions":"Carbon Monoxide Poisoning, Delayed Neurocognitive Sequelae","enrollment":128},{"nctId":"NCT04990232","phase":"PHASE2","title":"Personalized Immunotherapy in Sepsis","status":"COMPLETED","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2021-07-29","conditions":"Sepsis","enrollment":280},{"nctId":"NCT06211088","phase":"NA","title":"Famotidine Versus Placebo in Emergency Pediatric Surgery As a Risk to Postoperative Nausea and Vomiting","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2024-08-01","conditions":"Postoperative Nausea and Vomiting","enrollment":50},{"nctId":"NCT06857734","phase":"NA","title":"Analgesic and Anti-inflamatory Effect of Vit. B","status":"NOT_YET_RECRUITING","sponsor":"Benha University","startDate":"2025-03-01","conditions":"Postoperative Pain, Acute","enrollment":90},{"nctId":"NCT06353334","phase":"PHASE4","title":"Butylphthalide's Safety and Efficacy for Improving Neurological Function Prognosis in Patients With Cardiac Arrest (BNCA Trial)","status":"RECRUITING","sponsor":"Tang Ziren","startDate":"2021-09-01","conditions":"Butylphthalide, Cardiac Arrest, Neuroprotective Drugs","enrollment":100},{"nctId":"NCT06662019","phase":"PHASE1","title":"Phase I Safety Study of Inhaled N-IP-00001 to Determine Tolerability and Safety in Healthy Volunteers.","status":"COMPLETED","sponsor":"NeoTrials Pty Ltd","startDate":"2024-10-29","conditions":"Healthy","enrollment":8},{"nctId":"NCT05661669","phase":"PHASE2","title":"Ketamine for the Treatment for Alcohol Use Disorder in the ED","status":"WITHDRAWN","sponsor":"Brigham and Women's Hospital","startDate":"2023-09-01","conditions":"Alcohol Use Disorder","enrollment":""},{"nctId":"NCT04625725","phase":"PHASE3","title":"Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2020-11-21","conditions":"COVID-19","enrollment":5197},{"nctId":"NCT06624137","phase":"","title":"Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-12-12","conditions":"OCD, Major Depressive Disorder (MDD), Alcohol Use Disorder (AUD)","enrollment":200},{"nctId":"NCT06729047","phase":"PHASE1, PHASE2","title":"Prophylactic Intravenous Injection of Neostigmine Plus Atropine Versus Ketorolac on Post-dural Puncture Headache in Patients Undergoing Infraumbilical Surgeries","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-12-15","conditions":"Post-Dural Puncture Headache","enrollment":330},{"nctId":"NCT03503058","phase":"PHASE2","title":"Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria","status":"COMPLETED","sponsor":"Sanaria Inc.","startDate":"2022-05-07","conditions":"Malaria","enrollment":345},{"nctId":"NCT04806178","phase":"PHASE3","title":"Immunological Response of Bladder Cancer Patients Under BCG","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2021-09-03","conditions":"Bladder Cancer, Bacillus Calmette-Guerin","enrollment":30},{"nctId":"NCT04722003","phase":"PHASE2","title":"Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-11-01","conditions":"Gonorrhoea","enrollment":52},{"nctId":"NCT00780962","phase":"PHASE2","title":"N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2007-10-16","conditions":"Radiocontrast Nephropathy","enrollment":399},{"nctId":"NCT03755713","phase":"PHASE1","title":"A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2019-03-12","conditions":"Peanut Allergy","enrollment":20},{"nctId":"NCT05808166","phase":"PHASE2","title":"Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women","status":"RECRUITING","sponsor":"International Vaccine Institute","startDate":"2024-05-02","conditions":"Hepatitis E Infection","enrollment":2358},{"nctId":"NCT04315948","phase":"PHASE3","title":"Trial of Treatments for COVID-19 in Hospitalized Adults","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2020-03-22","conditions":"Corona Virus Infection","enrollment":1552},{"nctId":"NCT03392896","phase":"PHASE1","title":"Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria","status":"COMPLETED","sponsor":"Dicerna Pharmaceuticals, Inc., a Novo Nordisk company","startDate":"2017-12-06","conditions":"Primary Hyperoxaluria","enrollment":43},{"nctId":"NCT03772249","phase":"PHASE1","title":"Study of Safety and Tolerability of DCR HBVS","status":"COMPLETED","sponsor":"Dicerna Pharmaceuticals, Inc., a Novo Nordisk company","startDate":"2018-12-28","conditions":"Hepatitis B, Chronic","enrollment":82},{"nctId":"NCT05602493","phase":"PHASE3","title":"A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Efficacy and Safety of Topical Alendronic Acid on Alveolar Bone Remodeling After Tooth Extraction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Xeolas Pharmaceuticals Limited","startDate":"2022-11-22","conditions":"Bone Loss, Alveolar","enrollment":60},{"nctId":"NCT00558142","phase":"PHASE4","title":"Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2008-02","conditions":"Radiocontrast-induced Nephropathy","enrollment":107},{"nctId":"NCT06010368","phase":"PHASE3","title":"Comparing Intramyometrial Tranexamic Acid and Oxytocin for Blood Loss in Cesarean Section","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2024-10-01","conditions":"Cesarean Section Complications, Tranexamic Acid, Oxytocin","enrollment":150},{"nctId":"NCT03253328","phase":"EARLY_PHASE1","title":"N-Acetyl-Cysteine (NAC) for Healing of Amputation Stumps in the Setting of Diabetes","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-03-01","conditions":"Diabetes Mellitus, Critical Limb Ischemia, Lower Limb Amputation Knee","enrollment":33},{"nctId":"NCT05521152","phase":"PHASE3","title":"Norepinephrine for Prevention of Intraoperative Hypotension in Infants Undergoing Kasai Portoenterostomy","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2022-08-28","conditions":"Anesthesia, Pediatrics, Biliary Atresia","enrollment":31},{"nctId":"NCT06022224","phase":"PHASE2, PHASE3","title":"A 2nd Generation E1/E2B/E3-Deleted Adenoviral COVID-19 Vaccine: The TCELL VACCINE TRIAL","status":"TERMINATED","sponsor":"ImmunityBio, Inc.","startDate":"2020-12-09","conditions":"COVID-19","enrollment":35},{"nctId":"NCT04078022","phase":"PHASE2","title":"Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2020-03-02","conditions":"Shigella","enrollment":58},{"nctId":"NCT03222492","phase":"PHASE1, PHASE2","title":"Brentuximab Vedotin for Systemic Sclerosis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-09-20","conditions":"Diffuse Cutaneous Systemic Sclerosis, Scleroderma, dcSSc","enrollment":17},{"nctId":"NCT03903939","phase":"PHASE2","title":"Infusion of Prostacyclin vs Placebo for 72-hours in Trauma Patients With Haemorrhagic Shock Suffering From Organ Failure","status":"COMPLETED","sponsor":"Pär Johansson","startDate":"2019-05-22","conditions":"Multi Organ Failure","enrollment":228},{"nctId":"NCT04123444","phase":"PHASE2, PHASE3","title":"Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in Patients With Septic Shock Suffering From Organ Failure","status":"COMPLETED","sponsor":"Jakob Stensballe, MD, PhD","startDate":"2019-10-30","conditions":"Septic Shock","enrollment":279},{"nctId":"NCT04420741","phase":"PHASE2","title":"Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure","status":"COMPLETED","sponsor":"Pär Johansson","startDate":"2020-06-15","conditions":"COVID-19, Respiratory Failure","enrollment":80},{"nctId":"NCT05384678","phase":"PHASE1","title":"Acute Dose-dependent Effects of DMT in Healthy Subjects","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-11-15","conditions":"Healthy","enrollment":24},{"nctId":"NCT03989102","phase":"PHASE2","title":"Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Malaria Transmission Season in Healthy African Adult Women of Childbearing Potential in Mali","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-07-03","conditions":"Malaria","enrollment":324},{"nctId":"NCT05752799","phase":"NA","title":"Evaluation of the Stress Response in Bariatric Surgery With and Without the Use of Opioids","status":"RECRUITING","sponsor":"G.Gennimatas General Hospital","startDate":"2023-01-01","conditions":"Opioid Use, Unspecified, Bariatric Surgery Candidate","enrollment":70},{"nctId":"NCT03677830","phase":"PHASE4","title":"Postoperative Pain Control & Relief in Neonates","status":"TERMINATED","sponsor":"St. Louis University","startDate":"2019-04-19","conditions":"Pain, Postoperative, Premature Infant, Opioid Use","enrollment":11},{"nctId":"NCT00616304","phase":"PHASE2","title":"Safety and Preliminary Efficacy of L-arginine in Severe Falciparum Malaria","status":"SUSPENDED","sponsor":"Menzies School of Health Research","startDate":"2008-02","conditions":"Severe Falciparum Malaria","enrollment":8},{"nctId":"NCT05383560","phase":"PHASE2","title":"Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in Adults","status":"COMPLETED","sponsor":"Sheba Medical Center","startDate":"2022-09-05","conditions":"COVID-19 Pandemic, Immunogenicity, SARS CoV 2 Infection","enrollment":179},{"nctId":"NCT04516746","phase":"PHASE3","title":"Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2020-08-28","conditions":"COVID-19, SARS-CoV-2","enrollment":32450},{"nctId":"NCT06239714","phase":"PHASE1","title":"A Study to Evaluate SGB-3403 in Healthy Volunteers and Subjects With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)","status":"UNKNOWN","sponsor":"Suzhou Sanegene Bio Inc.","startDate":"2024-02-18","conditions":"Hyperlipidemias","enrollment":64},{"nctId":"NCT06220929","phase":"PHASE4","title":"Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury","status":"UNKNOWN","sponsor":"Sichuan Provincial People's Hospital","startDate":"2024-01-15","conditions":"Sepsis, Liver Dysfunction","enrollment":40},{"nctId":"NCT05215743","phase":"PHASE1","title":"Combined Antioxidant Therapy Against Myocardial Reperfusion Injury. Phase I Study.","status":"COMPLETED","sponsor":"University of Chile","startDate":"2022-08-09","conditions":"Acute Myocardial Infarction, Ischemia-reperfusion Injury, Reperfusion Injury, Myocardial","enrollment":18},{"nctId":"NCT03769714","phase":"PHASE4","title":"EXPAREL for Minimally Invasive Supracervical Hysterectomies","status":"COMPLETED","sponsor":"Maimonides Medical Center","startDate":"2018-10-01","conditions":"Pain","enrollment":60},{"nctId":"NCT06183008","phase":"PHASE4","title":"IVIG in Painful Sensory Neuropathy","status":"NOT_YET_RECRUITING","sponsor":"Sorlandet Hospital HF","startDate":"2024-02","conditions":"Sensory Neuropathy, Small Fiber Neuropathy","enrollment":20},{"nctId":"NCT04369794","phase":"PHASE4","title":"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2020-10-01","conditions":"COVID-19, Therapeutic Vaccine, BCG","enrollment":400},{"nctId":"NCT04625972","phase":"PHASE3","title":"Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2020-12-02","conditions":"COVID-19","enrollment":1131},{"nctId":"NCT04742842","phase":"PHASE1","title":"The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers","status":"COMPLETED","sponsor":"University of Sydney","startDate":"2021-06-21","conditions":"SARS-CoV2 COVID-19","enrollment":68},{"nctId":"NCT03378167","phase":"PHASE1","title":"PediCRaFT: Pediatric Crohn's Disease Fecal Transplant Trial","status":"COMPLETED","sponsor":"McMaster Children's Hospital","startDate":"2018-12-01","conditions":"Crohn Disease, Pediatric Crohns Disease, Inflammatory Bowel Diseases","enrollment":17},{"nctId":"NCT06076668","phase":"NA","title":"Dexmedetomidine Infusion Versus Oral Melatonin for Prevention of Intensive Care Delirium","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2023-10-16","conditions":"Dexmedetomidine, Melatonin, Delirium","enrollment":90},{"nctId":"NCT04680923","phase":"NA","title":"Efficacy of CPPLAI in Laparoscopic Sleeve Gastrectomy Patients","status":"COMPLETED","sponsor":"King Khalid University Hospital","startDate":"2020-12-08","conditions":"Obesity, Morbid, Pain, Postoperative","enrollment":120},{"nctId":"NCT05875948","phase":"PHASE2","title":"Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome","status":"UNKNOWN","sponsor":"River 2 Renal Corp.","startDate":"2023-06-30","conditions":"Hepatorenal Syndrome, Acute Kidney Injury","enrollment":95},{"nctId":"NCT05991128","phase":"PHASE4","title":"The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life","status":"UNKNOWN","sponsor":"China-Japan Friendship Hospital","startDate":"2023-08-01","conditions":"Heart Failure With Preserved Ejection Fraction, Iron Deficiencies, Acute Heart Failure","enrollment":170},{"nctId":"NCT03135834","phase":"PHASE3","title":"A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2017-04-24","conditions":"Meningococcal Vaccine","enrollment":1610},{"nctId":"NCT04364035","phase":"PHASE2","title":"Safety, Tolerability and Immunogenicity of MVA.HTI and ChAdOx1.HTI With Vesatolimod in HIV-1 Positive Patients","status":"COMPLETED","sponsor":"Aelix Therapeutics","startDate":"2020-02-20","conditions":"HIV/AIDS","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":78,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"N: Normal saline (placebo)","genericName":"N: Normal saline (placebo)","companyName":"B.P. Koirala Institute of Health Sciences","companyId":"b-p-koirala-institute-of-health-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Normal saline is an isotonic solution of sodium chloride that serves as a physiological vehicle for drug delivery or fluid replacement with no active pharmacological mechanism. Used for Placebo control in clinical trials, Vehicle for parenteral drug delivery.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}